Phase 4 Trial Shows Opsumit Can Improve Ventricle Function for Pulmonary Arterial Hypertension Patients
A recent Phase 4 study has shown that Opsumit can improve function of the right heart ventricle for patients with pulmonary arterial hypertension (PAH). The right ventricle pumps blood to…